Marpai, Inc. (MRAI) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US5713542083

Price
3.06 USD
Market cap
82.10 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Marpai, Inc. financials

Fiscal year2025
Revenue18.10 m USD
Gross profit4.78 m USD
Operating income-13.55 m USD
EBIT-13.33 m USD
Net income-16.56 m USD
Diluted EPS – continuing operations-0.95 USD

Full history since 2019, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Marpai, Inc.

Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company provides third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also offers in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company provides health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services. It serves the self-insured employer market through healthcare benefits brokers and consultants. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.